Prostate spindle cell neoplasm associated with early voiding difficulty after transurethral resection of the prostate

This report presents the case of 75-year-old men with spindle cell neoplasm. The patient underwent percutaneous nephrolithotomy and transurethral resection of the prostate (TURP) for renal stones and benign prostatic hyperplasia. One month postoperatively, the patient was able to void without any difficulty. Five months later, the patient experienced difficulty voiding and presented to the emergency room with severe pelvic pain. Computed tomography (CT) showed regrowth of the prostate mass into the posterior bladder and penile root. The prostate-specific antigen level remained constant at 1.14 ng/mL during the pre-and postoperative periods. Five months before the TURP operation, the patient’s CT scan showed a soft and mildly enlarged prostate with no protrusion into the bladder. Biopsy of the prostate, however, showed a protruding mass, indicative of a spindle cell neoplasm. The patient was subsequently treated with the chemotherapeutic drug adriamycin. Unfortunately, treatment was unsuccessful, and the patient died 18 months later.

[1]  Zhenlang Guo,et al.  Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: A retrospective study , 2022, Investigative and clinical urology.

[2]  T. Wilt,et al.  Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020. , 2020, The Journal of urology.

[3]  W. J. Brockway,et al.  Two Cases of Spindle Cell Neoplasms in Patients Undergoing Holmium Laser Enucleation of the Prostate. , 2019, Journal of endourology case reports.

[4]  M. Farag,et al.  Secondary spindle cell sarcoma following external beam radiotherapy for prostate cancer: a rare but devastating complication , 2018, BMJ Case Reports.

[5]  Choung-Soo Kim,et al.  Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study , 2018, Journal of Cancer Research and Clinical Oncology.

[6]  Jingchao Wei,et al.  Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: A case report. , 2016, Oncology letters.

[7]  H. Grönberg,et al.  Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study , 2011, Cancers.

[8]  C. Roehrborn,et al.  Benign prostatic hyperplasia: a progressive disease of aging men. , 2003, Urology.

[9]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[10]  T. Schuster,et al.  The relative amount of epithelium, muscle, connective tissue and lumen in prostatic hyperplasia as a function of the mass of tissue resected. , 1999, The Journal of urology.

[11]  H. Lepor Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. , 2004, Reviews in urology.